Long-term benefits and risks of drug-eluting compared to bare-metal stents in patients with versus without chronic kidney disease

Maria Wanitschek; Matthias Pfisterer; Anders Hvelplund; Stefano De Servi; Osmund Bertel; Raban Jeger; Peter Rickenbacher; Allan Iversen; Jan Skov Jensen; Soeren Galatius; Christoph Kaiser; Hannes Alber; for the BASKET-PROVE Investigators

doi:10.1016/j.ijcard.2013.01.257

Long-term benefits and risks of drug-eluting compared to bare-metal stents in patients with versus without chronic kidney disease

Maria Wanitschek, Matthias Pfisterer, Anders Hvelplund, Stefano De Servi, Osmund Bertel, Raban Jeger, Peter Rickenbacher, Allan Iversen, Jan Skov Jensen, Soeren Galatius, Christoph Kaiser, Hannes Alber, for the BASKET-PROVE Investigators

15 Citationer (Scopus)

Abstract

AIMS: Chronic kidney disease (CKD) is associated with worse outcomes in patients with coronary artery disease (CAD). How CKD influences the benefit-risk balance of drug-eluting stents (DES) versus bare-metal stents (BMS) is less known. METHODS AND RESULTS: In the multicentre BASKET-PROVE trial, 2314 patients in need of large coronary stenting (≥3.0mm) were randomised 2:1 to DES or BMS. In an a priori planned secondary analysis, outcomes were evaluated according to renal function defined by estimated glomerular filtration rates (eGFR; normal: eGFR≥60ml/min/1.73m(2); CKD: eGFR

Originalsprog	Engelsk
Tidsskrift	International Journal of Cardiology Research
Vol/bind	20
Udgave nummer	6
Sider (fra-til)	2381-8
DOI	https://doi.org/10.1016/j.ijcard.2013.01.257
Status	Udgivet - 3 okt. 2013

Adgang til dokumentet

10.1016/j.ijcard.2013.01.257

Citationsformater

Wanitschek, M., Pfisterer, M., Hvelplund, A., De Servi, S., Bertel, O., Jeger, R., Rickenbacher, P., Iversen, A., Jensen, J. S., Galatius, S., Kaiser, C., Alber, H., & for the BASKET-PROVE Investigators (2013). Long-term benefits and risks of drug-eluting compared to bare-metal stents in patients with versus without chronic kidney disease. International Journal of Cardiology Research, 20(6), 2381-8. https://doi.org/10.1016/j.ijcard.2013.01.257

Long-term benefits and risks of drug-eluting compared to bare-metal stents in patients with versus without chronic kidney disease. / Wanitschek, Maria; Pfisterer, Matthias; Hvelplund, Anders et al.
I: International Journal of Cardiology Research, Bind 20, Nr. 6, 03.10.2013, s. 2381-8.

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

Wanitschek, M, Pfisterer, M, Hvelplund, A, De Servi, S, Bertel, O, Jeger, R, Rickenbacher, P, Iversen, A, Jensen, JS, Galatius, S, Kaiser, C, Alber, H & for the BASKET-PROVE Investigators 2013, 'Long-term benefits and risks of drug-eluting compared to bare-metal stents in patients with versus without chronic kidney disease', International Journal of Cardiology Research, bind 20, nr. 6, s. 2381-8. https://doi.org/10.1016/j.ijcard.2013.01.257

@article{de841e1882f64277a0cf0044ecf1a64a,

title = "Long-term benefits and risks of drug-eluting compared to bare-metal stents in patients with versus without chronic kidney disease",

abstract = "AIMS: Chronic kidney disease (CKD) is associated with worse outcomes in patients with coronary artery disease (CAD). How CKD influences the benefit-risk balance of drug-eluting stents (DES) versus bare-metal stents (BMS) is less known. METHODS AND RESULTS: In the multicentre BASKET-PROVE trial, 2314 patients in need of large coronary stenting (≥3.0mm) were randomised 2:1 to DES or BMS. In an a priori planned secondary analysis, outcomes were evaluated according to renal function defined by estimated glomerular filtration rates (eGFR; normal: eGFR≥60ml/min/1.73m(2); CKD: eGFR",

author = "Maria Wanitschek and Matthias Pfisterer and Anders Hvelplund and {De Servi}, Stefano and Osmund Bertel and Raban Jeger and Peter Rickenbacher and Allan Iversen and Jensen, {Jan Skov} and Soeren Galatius and Christoph Kaiser and Hannes Alber and {for the BASKET-PROVE Investigators}",

year = "2013",

month = oct,

day = "3",

doi = "10.1016/j.ijcard.2013.01.257",

language = "English",

volume = "20",

pages = "2381--8",

journal = "International Journal of Cardiology Research",

publisher = "Bioinfo Publications",

number = "6",

}

TY - JOUR

T1 - Long-term benefits and risks of drug-eluting compared to bare-metal stents in patients with versus without chronic kidney disease

AU - Wanitschek, Maria

AU - Pfisterer, Matthias

AU - Hvelplund, Anders

AU - De Servi, Stefano

AU - Bertel, Osmund

AU - Jeger, Raban

AU - Rickenbacher, Peter

AU - Iversen, Allan

AU - Jensen, Jan Skov

AU - Galatius, Soeren

AU - Kaiser, Christoph

AU - Alber, Hannes

AU - for the BASKET-PROVE Investigators

PY - 2013/10/3

Y1 - 2013/10/3

N2 - AIMS: Chronic kidney disease (CKD) is associated with worse outcomes in patients with coronary artery disease (CAD). How CKD influences the benefit-risk balance of drug-eluting stents (DES) versus bare-metal stents (BMS) is less known. METHODS AND RESULTS: In the multicentre BASKET-PROVE trial, 2314 patients in need of large coronary stenting (≥3.0mm) were randomised 2:1 to DES or BMS. In an a priori planned secondary analysis, outcomes were evaluated according to renal function defined by estimated glomerular filtration rates (eGFR; normal: eGFR≥60ml/min/1.73m(2); CKD: eGFR

AB - AIMS: Chronic kidney disease (CKD) is associated with worse outcomes in patients with coronary artery disease (CAD). How CKD influences the benefit-risk balance of drug-eluting stents (DES) versus bare-metal stents (BMS) is less known. METHODS AND RESULTS: In the multicentre BASKET-PROVE trial, 2314 patients in need of large coronary stenting (≥3.0mm) were randomised 2:1 to DES or BMS. In an a priori planned secondary analysis, outcomes were evaluated according to renal function defined by estimated glomerular filtration rates (eGFR; normal: eGFR≥60ml/min/1.73m(2); CKD: eGFR

U2 - 10.1016/j.ijcard.2013.01.257

DO - 10.1016/j.ijcard.2013.01.257

M3 - Journal article

C2 - 23453439

VL - 20

SP - 2381

EP - 2388

JO - International Journal of Cardiology Research

JF - International Journal of Cardiology Research

IS - 6

ER -

Long-term benefits and risks of drug-eluting compared to bare-metal stents in patients with versus without chronic kidney disease

Abstract

Adgang til dokumentet

Fingeraftryk

Citationsformater